| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -43,275 | -21,221 | -164,040 | -100,625 |
| Depreciation and amortization | 62,914 | 62,008 | 65,324 | 134,591 |
| Net amortization of debt discounts, premiums and issuance costs | 2,329 | 11,848 | 20,121 | 45,973 |
| Payment of accreted interest on senior secured notes | 0 | 65,877 | 52,292 | 34,700 |
| Straight line rental income | 57 | 203 | 450 | 309 |
| Amortization of acquired real estate leases and other intangible assets, net | 29 | 30 | 29 | 54 |
| Loss on modification or early extinguishment of debt | 0 | -2,138 | -11,191 | -29,197 |
| Impairment of assets | 0 | 2,994 | 93,243 | 69,465 |
| Loss (gain) on sale of real estate | -1,207 | 13,759 | 1,260 | 102,711 |
| Gains on equity securities, net | NaN | 0 | NaN | NaN |
| Gain on insurance recoveries | 0 | 0 | 0 | 7,522 |
| Other non-cash adjustments, net | 226 | 349 | -221 | 231 |
| Unconsolidated joint venture distributions | 600 | 750 | 250 | 0 |
| Equity in net earnings of investees | 96 | 27,108 | 5,083 | 4,569 |
| Deferred leasing costs, net | 1,714 | 1,040 | 583 | 2,690 |
| Other assets | -20,766 | -8,520 | 22,600 | -11,427 |
| Accrued interest | -4,605 | 18,275 | -10,997 | 313 |
| Other liabilities | -29,530 | 2,884 | 17,641 | 12,114 |
| Net cash provided by (used in) operating activities | 8,342 | -20,110 | -49,285 | 49,777 |
| Real estate improvements | 35,166 | 32,434 | 40,558 | 73,831 |
| Proceeds from sale of real estate, net | 21,693 | 239,852 | 15,274 | 334,108 |
| Investment in alerislife inc | NaN | 0 | 0 | 0 |
| Proceeds from alerislife inc. tender offer | NaN | 0 | NaN | NaN |
| Equity method investment distributions | 27,200 | 0 | 31,400 | 17,000 |
| Contributions to unconsolidated joint ventures | 0 | 0 | 0 | 8,500 |
| Proceeds from insurance recoveries | 0 | 0 | 0 | 1,308 |
| Purchase of interest rate cap | 147 | 0 | 0 | 47 |
| Net cash provided by investing activities | 13,580 | 207,418 | 6,116 | 270,038 |
| Proceeds from issuance of senior secured notes, net | NaN | 0 | 369,375 | NaN |
| Proceeds from mortgage notes payable | 0 | 0 | 0 | 343,157 |
| Redemption of senior unsecured notes | NaN | 0 | 0 | 380,000 |
| Repayments of borrowings on credit facility | NaN | 0 | NaN | NaN |
| Redemption of senior secured notes | 0 | 266,633 | 244,813 | 238,555 |
| Repayment of other debt | 1,187 | 1,115 | 1,069 | 1,659 |
| Early extinguishment of debt settled in cash | 0 | 1,860 | 9,901 | 25,903 |
| Payment of debt issuance costs | 173 | 3,021 | 6,013 | 13,193 |
| Repurchase of common shares | 88 | 82 | 954 | 109 |
| Distributions to shareholders | 2,421 | 2,421 | 2,414 | 4,826 |
| Net cash used in financing activities | -3,869 | -275,132 | 104,211 | -321,088 |
| Increase in cash and cash equivalents and restricted cash | 18,053 | -87,824 | 61,042 | -1,273 |
| Cash and cash equivalents and restricted cash at beginning of period | 121,799 | 209,623 | 149,854 | NaN |
| Cash and cash equivalents and restricted cash at end of period | 139,852 | 121,799 | 209,623 | NaN |
DIVERSIFIED HEALTHCARE TRUST (DHC)
DIVERSIFIED HEALTHCARE TRUST (DHC)